-
1
-
-
79956084514
-
The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
-
doi: 10.1016/j.jalz.2011.03.008
-
Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., et al. (2011). The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 270-279. doi: 10.1016/j.jalz.2011.03.008
-
(2011)
Alzheimers Dement
, vol.7
, pp. 270-279
-
-
Albert, M.S.1
DeKosky, S.T.2
Dickson, D.3
Dubois, B.4
Feldman, H.H.5
Fox, N.C.6
-
2
-
-
84878223127
-
Translational outpatient memory clinic working group. Supporting evidence for using biomarkers in the diagnosis of MCI due to AD
-
doi: 10.1007/s00415-012-6694-0
-
Galluzzi, S., Geroldi, C., Amicucci, G., Bocchio-Chiavetto, L., Bonetti, M., Bonvicini, C., et al. (2013). Translational outpatient memory clinic working group. Supporting evidence for using biomarkers in the diagnosis of MCI due to AD. J. Neurol. 260, 640-650. doi: 10.1007/s00415-012-6694-0
-
(2013)
J. Neurol.
, vol.260
, pp. 640-650
-
-
Galluzzi, S.1
Geroldi, C.2
Amicucci, G.3
Bocchio-Chiavetto, L.4
Bonetti, M.5
Bonvicini, C.6
-
3
-
-
82955198535
-
Alzheimer's disease neuroimaging initiative. Predicting MCI outcome with clinically available MRI and CSF biomarkers
-
doi: 10.1212/WNL.0b013e3182343314
-
Heister, D., Brewer, J. B., Magda, S., Blennow, K., and McEvoy, L. K. (2011). Alzheimer's disease neuroimaging initiative. Predicting MCI outcome with clinically available MRI and CSF biomarkers. Neurology 77, 1619-1628. doi: 10.1212/WNL.0b013e3182343314
-
(2011)
Neurology
, vol.77
, pp. 1619-1628
-
-
Heister, D.1
Brewer, J.B.2
Magda, S.3
Blennow, K.4
McEvoy, L.K.5
-
4
-
-
44449179423
-
Biomarcadores para la Enfermedad de Alzheimer y otras demencias degenerativas
-
Martínez-Rivera, M., Menénedez-González, M., and Pérez-Piñera, P. (2008). Biomarcadores para la Enfermedad de Alzheimer y otras demencias degenerativas. Archivos de Medicina 4:3.
-
(2008)
Archivos de Medicina
, vol.4
, pp. 3
-
-
Martínez-Rivera, M.1
Menénedez-González, M.2
Pérez-Piñera, P.3
-
5
-
-
79956098248
-
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
-
doi: 10.1016/j.jalz.2011.03.003
-
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., et al. (2011). Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 280-292. doi: 10.1016/j.jalz.2011.03.003
-
(2011)
Alzheimers Dement
, vol.7
, pp. 280-292
-
-
Sperling, R.A.1
Aisen, P.S.2
Beckett, L.A.3
Bennett, D.A.4
Craft, S.5
Fagan, A.M.6
-
6
-
-
84898042082
-
Alzheimer'CSF test: useful or useless?
-
Wilner, A. N. (2010). Alzheimer'CSF test: useful or useless? Medscape.
-
(2010)
Medscape
-
-
Wilner, A.N.1
|